Augmentative transcranial direct current stimulation (tDCS) in poor responder depressed patients: A follow-up study

CNS Spectrums

Volumn 19, Issue 4, 2014, Pages 347-354

  Dell'Osso, Bernardo ^a   Dobrea, Cristina ^a   Arici, Chiara ^a   Benatti, Beatrice ^a   Ferrucci, Roberta ^a   Vergari, Maurizio ^a   Priori, Alberto ^a   Altamura, A Carlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Bipolar disorder; follow up observation; major depressive disorder; poor response; transcranial direct current stimulation (tDCS)

Indexed keywords

ARIPIPRAZOLE; CLOMIPRAMINE; DULOXETINE; HALOPERIDOL DECANOATE; LORAZEPAM; MIRTAZAPINE; PAROXETINE; PREGABALIN; QUETIAPINE; SERTRALINE; TRAZODONE; VALPROIC ACID; VENLAFAXINE; ANTIDEPRESSANT AGENT;

ABSENCE OF COMPLICATIONS; ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DISEASE EXACERBATION; EVALUATION STUDY; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OPEN STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; TRANSCRANIAL DIRECT CURRENT STIMULATION; TREATMENT DURATION; YOUNG MANIA RATING SCALE; ANXIETY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; MEDICAL HISTORY; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT SAFETY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REMISSION; SOMATIZATION; SYMPTOM; TIME SERIES ANALYSIS; TREATMENT RESPONSE; AGED; CLINICAL TRIAL; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; TRANSCRANIAL DIRECT CURRENT STIMULATION; TREATMENT OUTCOME;

EID: 84906552529     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852913000497     Document Type: Article

References (41)

1. WHO. The world health report. Chap. 2.4, Geneva, Switzerland: World Health Organization; 2001. Available at http://www.who.int/whr/2001/en/whr01-en. pdf.
2. Nemeroff CB. Prevalence and management of treatment resistant depression. J Clin Psychiatry. 2007; 68(suppl. 8): 17-25. (Pubitemid 47184567)
3. Sackeim HA. The definition and meaning of treatmentresistant depression. J Clin Psychiatry. 2001; 62(suppl. 16): 10-17.
4. Carvajal C. Poor response to treatment: beyond medication. Dialogues Clin Neurosci. 2004; 6: 93-103. (Pubitemid 38435737)
5. Bauer M, Whybrow PC, Angst J, et al. World Federation of Societies of Biological Psychiatry (WFSBP). Guidelines for biological treatment of unipolar depressive disorders, part 2: maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry. 2002; 3: 69-86.
6. Kennedy SH, Milev R, Giacobbe P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. J Affect Disord. 2009; 117(suppl. 1): S44-S53.
7. Fregni F, Boggio PS, Nitsche MA, et al. Treatment of major depression with transcranial direct current stimulation. Bipolar Disord. 2006; 8: 203-204. (Pubitemid 44026775)
8. Boggio PS, Rigonatti SP, Ribeiro RB, et al. A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int J Neuropsychopharmacol. 2008; 11: 249-254. (Pubitemid 351231819)
9. Rigonatti SP, Boggio PS, Myczkowski ML, et al. Transcranial direct stimulation and fluoxetine for the treatment of depression. Eur Psychiatry. 2008; 23: 74-76. (Pubitemid 351222740)
10. Ferrucci R, Bortolomasi M, Vergari M, et al. Transcranial direct current stimulation in severe, drug-resistant major depression. J Affect Disord. 2009; 118: 215-219.
11. Loo CK, Sachdev P, Martin D, et al. A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int J Neuropsychopharmacol. 2010; 13: 61-69.
12. Brunoni AR, Ferrucci R, Bortolomasi M, et al. Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2011; 35: 96-101.
13. Blumberger DM, Tran LC, Fitgerald PB, Hoy KE, Daskalakis ZJ. A randomized double-blind shamcontrolled study of transcranial direct current stimulation for treatment-resistant major depression. Front Psychiatry. 2012; 3: 74.
14. Loo CK, Alonzo A, Martin D, et al. Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial. Br J Psychiatry. 2012; 200: 52-59.
15. Palm U, Schiller C, Fintescu Z, et al. Transcranial direct current stimultation in treatment resistant depression: a randomized double-blind, placebo-controlled study. Brain Stimul. 2012; 5(3): 242-251.
16. Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol. 2000; 527: 633-639.
17. Nitsche MA, Paulus W. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology. 2001; 57: 1899-1901. (Pubitemid 33096705)
18. Grimm S, Beck J, Schuepbach D, et al. Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder. Biol Psychiatry. 2008; 63: 369-376.
19. Dell'Osso B, Zanoni S, Ferrucci R, et al. Transcranial direct current stimulation for the outpatient treatment of poor-responder depressed patients. Eur Psychiatry. 2012; 27(7): 513-517.
20. Dell'Osso B, Priori A, Altamura AC. Efficacy and safety of transcranial direct current stimulation in major depression. Biol Psychiatry. 2011; 69: e23-24.
21. Ardolino G, Bossi B, Barbieri S, Priori A. Non-synaptic mechanisms underlie the after-effects of cathodal transcutaneous direct current stimulation of the human brain. J Physiol. 2005; 568: 653-663. (Pubitemid 41555464)
22. Liebetanz D, Fregni F, Monte-Silva KK, et al. Aftereffects of transcranial direct current stimulation (tDCS) on cortical spreading depression. Neurosci Lett. 2006; 398: 85-90.
23. Kalu UG, Sexton CE, Loo CK, Ebmeier KP. Transcranial direct current stimulation in the treatment of major depression: a meta-analysis. Psychol Med. 2012; 42(9): 1791-2000.
24. Brunoni AR, Valiengo L, Baccaro A, et al. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiatry. 2013; 70(4): 383-391.
25. Martin DM, Alonzo A, Ho KA, et al. Continuation transcranial direct current stimulation for the prevention of relapse in major depression. J Affect Disord. 2013; 144(3): 274-278.
26. Valiengo L, Benseñor IM, Goulart AC, et al. The sertraline versus electrical current therapy for treating depression clinical study (select-tdcs): results of the crossover and follow-up phases. Depress Anxiety. 2013; 30(7): 646-653.
27. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23: 56-62.
28. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979; 134: 382-389. (Pubitemid 9136500)
29. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978; 133: 429-435. (Pubitemid 9006756)
30. Bech P, Allerup P, Gram LF, et al. The Hamilton depression scale. Evaluation of objectivity using logistic models. Acta Psychiatr Scand. 1981; 63: 290-299. (Pubitemid 11137960)
31. Nierenberg AA, DeCecco LM. Definitions of antidepressant treatment response, remission, non response, partial response, and other relevant outcomes: a focus on treatment resistant depression. J Clin Psychiatry. 2001; 62(suppl. 16): 5-9.
32. Martin DM, Alonzo A, Mitchell PB, et al. Frontoextracephalic transcranial direct current stimulation as a treatment for major depression: An open-label pilot study. J Affect Disord. 2011; 134(1-3): 459-463.
33. Galvez V, Alonzo A, Martin D, et al. Hypomania induction in a patient with bipolar II disorder by transcranial direct current stimulation (tDCS). J ECT. 2011; 27(3): 256-258.
34. O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007; 62: 1208-1216. (Pubitemid 350060890)
35. Groves DA, Brown VJ. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci Biobehav Rev. 2005; 29: 493-500.
36. Lozano AM, Giacobbe P, Hamani C, et al. A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg. 2012; 116(2): 315-322.
37. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001; 285: 1299-1307. (Pubitemid 32216144)
38. Navarro V. Improving medication compliance in patients with depression: use of orodispersible tablets. Adv Ther. 2010; 27: 785-795.
39. Gourion D, Galinowski A, Baraille L, Picard H. [Switch antidepressants: when? how? why?] Encephale. 2011; 37(suppl 1): S50-S57. In French.
40. Brunoni AR, Ferrucci R, Bortolomasi M, et al. Interactions between transcranial direct current stimulation (tDCS) and pharmacological treatments in major depression. Eur Psychiatry. In press. DOI: 10.1016/j.eurpsy.2012.09.001.
41. Brunoni AR, Fraguas R, Fregni F. Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability. Ther Clin Risk Manag. 2009; 5: 897-910.